Spherix closes private placement of common stock, terminates private offering

Spherix Incorporated (NASDAQ: SPEX) (the "Company") today announced that it has closed a private placement of common stock and warrants and terminated the private offering. Laidlaw & Co (UK) Ltd. served as exclusive placement agent in connection with the private offering. The Company is an intellectual property development company committed to the fostering and monetization of intellectual property.

The gross proceeds to the Company before deduction of placement agent fees and offering expenses was approximately $4.4 million.  Net proceeds from the offering are expected to be used for working capital and general corporate purposes.

 

Source:

Spherix Incorporated

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.